OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
13
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Proteomics
(2)
Organisms
Alphavirus
(2)
Anemia
(2)
Betaherpesvirinae
(2)
Borrelia
(2)
Clostridium perfringens
(2)
Cowpox virus
(2)
Coxsackievirus
(2)
Cytomegalovirus
(2)
Dengue virus
(2)
EFO:0001352
(2)
Filoviridae
(2)
Hepatitis B virus
(2)
Human alphaherpesvirus 1
(2)
Human betaherpesvirus 5
(2)
Human immunodeficiency virus
(2)
Influenza A virus
(2)
Influenza C virus
(2)
Japanese encephalitis virus group
(2)
Listeria monocytogenes
(2)
Mammarenavirus
(2)
Miscanthus x giganteus
(2)
Mycobacterium tuberculosis
(2)
NCBITaxon:186536
(2)
Oropouche virus
(2)
Orthopoxvirus vaccinia
(2)
Rattus
(2)
Staphylococcus aureus
(2)
Streptococcus pneumoniae
(2)
Viruses
(2)
cellular organisms
(2)
Repository
pride
(2)
Technology Type
Mass Spectrometry
(2)
Shotgun proteomics
(2)
Publication Date
2023
(1)
2019
(1)
Release Date
2021
(4)
2022
(2)
2025
(1)
2024
(1)
2020
(1)
2019
(1)
2018
(1)
Lab affiliation
Faculty of Medicine and Health Technology, FI-33014, Tampere University, Finland
(1)
Institute of Medical Microbiology University of Zurich Gloriastrasse 28/30 CH-8006 Zürich/Switzerland Office: +41 (0)44 634 53 96 Lab1: +41 (0)44 634 53 24 Lab2: +41 (0)44 634 53 37 homepage: http://www.imm.uzh.ch/research/experimental/teamseeger.html Attachments area
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
A Potent Sybody Selectively Inhibits α-Synuclein Amyloid Formation by Binding to the P1 Region.
Not available
S-EPMC11215725
|
biostudies-literature
Cite
The extracellular gate shapes the energy profile of an ABC exporter.
Not available
S-EPMC6529423
|
biostudies-literature
Cite
Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance.
Not available
S-EPMC8982573
|
biostudies-literature
Cite
Generation of synthetic nanobodies against delicate proteins.
Not available
S-EPMC7617899
|
biostudies-literature
Cite
Synthetic single domain antibodies for the conformational trapping of membrane proteins.
Not available
S-EPMC5967865
|
biostudies-literature
Cite
Structures of synthetic nanobody-SARS-CoV-2-RBD complexes reveal distinct sites of interaction and recognition of variants.
Not available
S-EPMC8219104
|
biostudies-literature
Cite
A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2.
Not available
S-EPMC7959386
|
biostudies-literature
Cite
Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction.
Not available
S-EPMC8444450
|
biostudies-literature
Cite
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.
Not available
S-EPMC8324831
|
biostudies-literature
Cite
Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance
Not available
S-SCDT-EMBOR-2021-54199V1
|
biostudies-other
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
